Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Pabinger

Showing results (131-140 of 367) with videos related to

Pageof 37
Sort By:
Thrombosis and Haemostasis|October 17, 2007
The angiotensin-converting enzyme insertion/deletion polymorphism and serum levels of angiotensin-converting enzyme in venous thromboembolism. Data from a case control studyCihan Ay, Peter Bencur, Rainer Vormittag, et al.
Neuro-Oncology|March 1, 2007
Venous thromboembolism and survival in patients with high-grade gliomaRalph Simanek, Rainer Vormittag, Marco Hassler, et al.
International Journal of Laboratory Hematology|November 1, 2020
Limitations of a calibrated, quantitative APC-R assay under routine conditionsPetra Jilma-Stohlawetz, Katharina Lysy, Raute Sunder-Plassmann, et al.
Blood|March 27, 2015
Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)Johanna Gebhart, Florian Posch, Silvia Koder, et al.
Haematologica|March 13, 2025
Hemophilia is associated with accelerated biological agingMarina Trappl, Rafaela Vostatek, Manuel Salzmann, et al.
Annals of Hematology|May 31, 2015
Anti-coagulation assessment with prothrombin time and anti-Xa assays in real-world patients on treatment with rivaroxabanOliver Königsbrügge, Peter Quehenberger, Sabine Belik, et al.
Oncology Research and Treatment|September 21, 2018
Immune Thrombocytopenia - Current Diagnostics and Therapy: Recommendations of a Joint Working Group of DGHO, ÖGHO, SGH, GPOH, and DGTIAxel Matzdorff, Oliver Meyer, Helmut Ostermann, et al.
Nature Genetics|March 17, 2009
A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasmsDamla Olcaydu, Ashot Harutyunyan, Roland Jäger, et al.
Haematologica|February 29, 2012
High D-dimer levels are associated with poor prognosis in cancer patientsCihan Ay, Daniela Dunkler, Robert Pirker, et al.
ESMO Open|November 24, 2020
Prevention of venous thromboembolism in ambulatory patients with cancerAlok A Khorana, Alexander T Cohen, Marc Carrier, et al.
Pageof 37

Showing results (131-140 of 367) with videos related to

Sort By:
Pageof 37
Thrombosis and Haemostasis|October 17, 2007
The angiotensin-converting enzyme insertion/deletion polymorphism and serum levels of angiotensin-converting enzyme in venous thromboembolism. Data from a case control studyCihan Ay, Peter Bencur, Rainer Vormittag, et al.
Neuro-Oncology|March 1, 2007
Venous thromboembolism and survival in patients with high-grade gliomaRalph Simanek, Rainer Vormittag, Marco Hassler, et al.
International Journal of Laboratory Hematology|November 1, 2020
Limitations of a calibrated, quantitative APC-R assay under routine conditionsPetra Jilma-Stohlawetz, Katharina Lysy, Raute Sunder-Plassmann, et al.
Blood|March 27, 2015
Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)Johanna Gebhart, Florian Posch, Silvia Koder, et al.
Haematologica|March 13, 2025
Hemophilia is associated with accelerated biological agingMarina Trappl, Rafaela Vostatek, Manuel Salzmann, et al.
Annals of Hematology|May 31, 2015
Anti-coagulation assessment with prothrombin time and anti-Xa assays in real-world patients on treatment with rivaroxabanOliver Königsbrügge, Peter Quehenberger, Sabine Belik, et al.
Oncology Research and Treatment|September 21, 2018
Immune Thrombocytopenia - Current Diagnostics and Therapy: Recommendations of a Joint Working Group of DGHO, ÖGHO, SGH, GPOH, and DGTIAxel Matzdorff, Oliver Meyer, Helmut Ostermann, et al.
Nature Genetics|March 17, 2009
A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasmsDamla Olcaydu, Ashot Harutyunyan, Roland Jäger, et al.
Haematologica|February 29, 2012
High D-dimer levels are associated with poor prognosis in cancer patientsCihan Ay, Daniela Dunkler, Robert Pirker, et al.
ESMO Open|November 24, 2020
Prevention of venous thromboembolism in ambulatory patients with cancerAlok A Khorana, Alexander T Cohen, Marc Carrier, et al.
Pageof 37